Novartis AGNVSNYSE
Loading
ROE: Strong ReturnsExpanding
Percentile Rank86
3Y CAGR+39.4%
5Y CAGR+17.4%
Studio
Year-over-Year Change

Return on equity

3Y CAGR
+39.4%/yr
vs -7.5%/yr prior
5Y CAGR
+17.4%/yr
Recent acceleration
Acceleration
+47.0pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
2.2x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
202531.78%+17.2%
202427.11%-14.8%
202331.82%+171.5%
202211.72%-67.0%
202135.51%+148.9%
202014.26%-32.6%
201921.15%+31.8%
201816.04%+54.5%
201710.39%+15.8%
20168.97%-